Lupuzor phase 3 to start

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

New Member

Date Joined Oct 2013
Total Posts : 10
   Posted 1/22/2015 3:43 AM (GMT -6)   
The clinical study is titled "A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus". It is a pivotal study designed to demonstrate the safety and efficacy of IPP-201101 and as a last step prior to the filing of the drug for approval with the US Food & Drug Administration ("FDA") and the European Medicines Agency ("EMA").
New Topic Post Reply Printable Version
Forum Information
Currently it is Wednesday, March 21, 2018 12:52 PM (GMT -6)
There are a total of 2,942,322 posts in 322,842 threads.
View Active Threads

Who's Online
This forum has 161230 registered members. Please welcome our newest member, Silkgod.
373 Guest(s), 16 Registered Member(s) are currently online.  Details
81GyGuy, Kent M., breakthecycle, sandyfeet, JNF, Serenity Now, Lcitti3, Kat1000, scoobymummy, HiketoHealing, 142, Herophilus, SharonZ, ChickenArise, mr bill, straydog